Richard DiMarchi

Richard D.
DiMarchi is the founder of Assembly Pharmaceuticals, Inc. (founded in 2013), Marcadia Biotech, Inc. (founded in 2005), Calibrium LLC (founded in 2013), Ambrx, Inc. (founded in 2003), and MBX Biosciences, Inc. (founded in 2018).
He held the title of Director & Chief Scientific Officer at Marcadia Biotech, Inc., Member-Managers Board & Chief Scientific Officer at Calibrium LLC, and Director & Chief Scientific Officer at MBX Biosciences, Inc. Dr. DiMarchi is also the founder of MB2 LLC.
Dr. DiMarchi's current job(s) include being a Board of Director at BioCrossroads, a Professor-Biochemistry at Indiana University, and a Partner at Twilight Venture Partners LLC.
Dr. DiMarchi's former job(s) include being a Director at Ionis Pharmaceuticals, Inc. (from 2004 to 2011), a Director at Biotechnology Innovation Organization, a Director at Millennium Biotherapeutics, Inc., an Independent Director at Assembly Biosciences, Inc. (from 2014 to 2023), and a Group Vice President at Eli Lilly & Co. (from 1992 to 2003).
He also served as an Advisor at Thomas, McNerney & Partners LLC.
Dr. DiMarchi's education history includes an undergraduate degree from Florida Atlantic University and a doctorate degree from Indiana University (conferred in 1979).